Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial

Ulrich Hacker, Dirk Hasenclever, R. Baber, Nicolas Linder, Harald Busse, Radka Obermannová, Lenka Zdražilová Dubská, Dalibor Valík, Florian Lordick